Instem Releases Version 9 of Provantis
Instem, a leading provider of IT solutions  to the global early development healthcare market, is pleased to announce the release of version 9 of its world-leading, preclinical software suite, Provantis® .
Version 9 was developed in close collaboration with Instem clients as part of its overarching Customer Involvement Program (CIP). This included a comprehensive Beta Test Program involving valued clients such as Bristol-Myers Squibb, GlaxoSmithKline, MPI Research, Roche, Sanofi and Sequani, as well as Webcasts, product demonstrations, Special Interest Group meetings and dedicated sessions at the Instem International Conferences.
The eagerly anticipated release contains major enhancements to the Clinical Pathology module , delivering a more flexible, scalable, cost-effective and highly efficient sample-driven solution. Provantis 9 offers Clinical Pathology professionals a complete, end-to-end, integrated solution, which delivers additional efficiency gains at each step of the way; from the taking of the sample, through the Clinical Pathology laboratory, to the presentation of results.
Provantis version 9 also contains:
In addition to new capabilities at the application level, Provantis version 9 also incorporates a major technology upgrade, ensuring that clients are able to take advantage of the latest investments in 64-bit technology and the Oracle and Microsoft platforms.
Mike Harwood, Instem’s Senior Vice President, comments, “Client feedback throughout this development project has been extremely positive and has helped to ensure that version 9 is a robust, high quality, fit-for-purpose application for the Tox/Path market. The features included in version 9 are in high demand; numerous clients have committed to upgrading with several more poised to sign shortly.”
Provantis 9 is a comprehensive release that will be supported by a global awareness program aimed at demonstrating the specific benefits it brings in terms of increased productivity, ease of use and efficiency gains in the short and longer terms. This will begin with a series of launch Webcasts taking place during the week of Monday, February 11th.
Existing Instem clients can choose from one of the following
identical launch Webcasts:
Thursday, February 14th: 9:30am-10am US EST/2:30pm-3pm UK GMT 
Thursday, February 14th: 2:30pm-3pm US EST/7:30pm-8pm UK GMT 
Prospective clients, vendors, consultants and media are invited to
attend one of the following identical launch Webcasts:
Wednesday, February 20th: 9:30am-10am US EST/2:30pm-3pm UK GMT 
Wednesday, February 20th: 1:30pm-2pm US EST/6:30pm-7pm UK GMT 
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions  for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes  while offering the unique ability to generate new knowledge  through the extraction and harmonization  of actionable scientific information.
Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com .
Do more. Go further™.